Abeona Therapeutics Inc.
Abeona Therapeutics Inc.（ABEO）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ABEO · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
33
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Abeona Therapeutics Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ABEO 季度内部人买卖趋势
ABEO 内幕交易卖出 · ABEO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ABEO CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ABEO 高管卖出股份 · ABEO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 26, 2026 | Alvino Mark Director | Gift | 500 | — | Form 4 |
| May 22, 2026 | Alvino Mark Director | Sale | 6,500 | $35K | Form 4 |
| May 15, 2026 | Crombez Eric Director | Sale | 26,143 | $145K | Form 4 |
| May 11, 2026 | Vasanthavada Madhav Chief Commercial Officer | Sale | 5,548 | $33K | Form 4 |
| Apr 1, 2026 | Goldan Keith A. Director | Award | 32,751 | — | Form 4 |
| Mar 31, 2026 | Seshadri Vishwas CEO · Director | Sale | 29,985 | $131K | Form 4 |
| Mar 16, 2026 | Vazzano Joseph Walter CFO | Sale | 785 | $4K | Form 4 |
| Feb 2, 2026 | Silverstein Christine Berni Director | Sale | 20,070 | $102K | Form 4 |
| Feb 2, 2026 | Wuchterl Donald A. Director | Sale | 14,814 | $75K | Form 4 |
| Feb 2, 2026 | Crombez Eric Director | Sale | 16,284 | $83K | Form 4 |
| Feb 2, 2026 | Alland Leila Director | Sale | 18,065 | $92K | Form 4 |
| Feb 2, 2026 | Alvino Mark Director | Sale | 2,000 | $10K | Form 4 |
| Jan 26, 2026 | Wuchterl Donald A. Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Zeiher Bernhardt G Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Crombez Eric Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Silverstein Christine Berni Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Amoroso Michael Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Charles Faith L. Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Alvino Mark Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Alland Leila Director | Award | 37,313 | — | Form 4 |
| Jan 20, 2026 | Vasanthavada Madhav Chief Commercial Officer | Award | 76,621 | — | Form 4 |
| Jan 22, 2026 | Vasanthavada Madhav Chief Commercial Officer | Sale | 12,610 | $67K | Form 4 |
| Jan 22, 2026 | Vazzano Joseph Walter CFO | Sale | 18,666 | $100K | Form 4 |
| Jan 22, 2026 | Seshadri Vishwas CEO · Director | Sale | 69,832 | $372K | Form 4 |
| Jan 22, 2026 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | 13,578 | $72K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ABEO 内幕交易
ABEO 内幕交易
Abeona Therapeutics Inc.（ABEO）内幕交易数据来源于公司内部人（包括Seshadri Vishwas (CEO · Director), Alvino Mark (Director), Vazzano Joseph Walter (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ABEO内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Abeona Therapeutics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ABEO 内幕交易 · 5个问题Abeona Therapeutics Inc.（ABEO）的内部人包括高管和董事，如Seshadri Vishwas (CEO · Director), Alvino Mark (Director), Vazzano Joseph Walter (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026